Atgenomix is a cloud-native precision medicine software company leveraging cutting-edge data and AI technologies. Our primary focus is to revolutionize laboratory developed testing (LDT) by offering advanced computational and analytics solutions. By addressing diagnostic demands, we aim to bridge crucial gaps in the industry, ensuring high-quality, scalable, and tailored biomedical testing solutions.

Atgenomix SeqsLab Platform, purposefully formulated by Atgenomix, stands as an open standard and unified cloud platform. It empowers genomic testing providers to expand their clinical diagnostics portfolio on a global scale. Additionally, it enables clinical researchers to expedite large-scale omics data processing while allowing bioinformatics scientists to introduce new analysis software products rapidly.

Atgenomix SeqsLab is actively operational in over 10 medical centers and LDT-capable laboratories. The primary solution lies in delivering precision oncology, facilitating rare disease diagnosis, supporting reproductive medicine, enabling prenatal diagnosis, and addressing complex disease susceptibility. This versatile platform serves as a comprehensive solution catering to various specialized areas within the realm of genomics and diagnostics.

Atgenomix follows the most relevant frameworks and rigorous compliance standards in the healthcare industry: GA4GH, GDPR, HIPAA, ISO/IEC 27001, IEC 62304, ISO/IEC 27018, FDA/MDCG cybersecurity guidance, FDA 21 CFR Part 11 audit trail, and more.